01:19 , May 24, 2012 |  BC Extra  |  Company News

Vertex's Boger joins eye company Alkeus

Alkeus Pharmaceuticals Inc. (Boston, Mass.) appointed Joshua Boger as executive chairman. Boger is the founder of Vertex Pharmaceuticals Inc. (NASDAQ:VRTX), where he served as CEO until his retirement in May 2009. Boger remains a member...
08:00 , Jan 26, 2012 |  BC Innovations  |  Targets & Mechanisms

Visum sees the light

Researchers at Case Western Reserve University have identified 16 approved drugs that could help treat Stargardt's disease and dry age-related macular degeneration by preventing the toxic buildup of visual cycle byproducts.1Visum Therapeutics Inc. has licensed...
07:00 , Jun 30, 2011 |  BC Innovations  |  Cover Story

Ab's dry (AMD) humor

A collaborative effort by Pfizer Inc. and U.S. academicshas found that immunotherapy against beta-amyloid can reverse the retinal protein deposition that leads to dry age-related macular degeneration. The finding could open up a repurposing opportunity...
07:00 , Sep 29, 2008 |  BioCentury  |  Product Development

The eyes have it

Continued increases in investment, new targets and expanded delivery options signal growing interest in ophthalmics, resulting in nearly 40 deals since January 2007, led by Novartis AG's $10.4 billion purchase of a 25% stake in...